Value of input used to measure equity securities without readily determinable fair value.

No definition available.

Name:	atos_EquitySecuritiesWithoutReadilyDeterminableFairValueMeasurementInput
Namespace Prefix:	atos_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of cash outflow to acquire investment in equity security without readily determinable fair value.

+ References

No definition available.

+ Details

Name:	atos_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
Namespace Prefix:	atos_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of impairment loss on investment in equity security without readily determinable fair value.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 321
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479536/321-10-50-3

+ Details

Name:	us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 5A
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A

+ Details

Name:	us-gaap_VariableInterestEntityOwnershipPercentage
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_MeasurementInputTypeAxis=atos_MeasurementInputProbabilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ValuationTechniqueAxis=atos_ValuationDynamicOptionsApproachMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ValuationTechniqueAxis=us-gaap_CostApproachValuationTechniqueMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ConsolidatedEntitiesAxis=atos_DynamicCellTherapiesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=atos_DynamicCellTherapiesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Note 4 - Investment in Equity Securities (Details Textual) $ in Thousands		3 Months Ended		6 Months Ended	9 Months Ended
	Dec. 23, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2023 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount		$ (0)	$ (0)	$ 2,990	$ 2,990	$ (0)
Measurement Input, Expected Term [Member]
Equity Securities without Readily Determinable Fair Value, Measurement Input				3.5
Measurement Input, Probability [Member] \| Valuation, Dynamic Options Approach [Member]
Equity Securities without Readily Determinable Fair Value, Measurement Input				0.50
Measurement Input, Probability [Member] \| Valuation, Cost Approach [Member]
Equity Securities without Readily Determinable Fair Value, Measurement Input				0.50
Dynamic Cell Therapies, Inc. [Member]
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage	19.00%
Dynamic Cell Therapies, Inc. [Member]
Payments to Acquire Equity Securities without Readily Determinable Fair Value	$ 4,700